| 1 |
Mowery NT, Terzian WTH, Nelson AC. Acute lung injury[J]. Curr Probl Surg, 2020, 57 (5): 100777.
|
| 2 |
滕飞，贾玲玲，赵希伟，等.外泌体在急性肺损伤/急性呼吸窘迫综合征中的研究进展[J/CD].中华危重症医学杂志（电子版），2021，14（3）：252-256.
|
| 3 |
Zhou H, Fan EK, Fan J. Cell-cell interaction mechanisms in acute lung injury[J]. Shock, 2021, 55 (2): 167-176.
|
| 4 |
Butt Y, Kurdowska A, Allen TC. Acute lung injury: a clinical and molecular review[J]. Arch Pathol Lab Med, 2016, 140 (4): 345-350.
|
| 5 |
Shapouri-Moghaddam A, Mohammadlan S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease[J]. J Cell Physiol, 2018, 233 (9): 6425-6440.
|
| 6 |
Artyomov MN, Sergushichev A, Schilling JD. Integrating immunometabolism and macrophage diversity[J]. Semin Immunol, 2016, 28 (5): 417-424.
|
| 7 |
Chorro L, Sarde A, Li M, et al. Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network[J]. J Exp Med, 2009, 206 (13): 3089-3100.
|
| 8 |
Hume DA, Irvine KM, Pridans C. The mononuclear phagocyte system: the relationship between monocytes and macrophages[J]. Trends Immunol, 2019, 40 (2): 98-112.
|
| 9 |
Mu X, Li Y, Fan GC. Tissue-resident macrophages in the control of infection and resolution of inflammation[J]. Shock, 2021, 55 (1): 14-23.
|
| 10 |
Mass E, Ballesteros I, Farlik M, et al. Specification of tissue-resident macrophages during organogenesis[J]. Science, 2016, 353 (6304): aaf4238.
|
| 11 |
Lim PN, Cervantes MM, Pham LK, et al. Alveolar macrophages: novel therapeutic targets for respiratory diseases[J]. Expert Rev Mol Med, 2021 (23): e18.
|
| 12 |
Bissonnette EY, Lauzon-Joset JF, Debley JS, et al. Cross-talk between alveolar macrophages and lung epithelial cells is essential to maintain lung homeostasis[J]. Front Immunol, 2020 (11): 583042.
|
| 13 |
Schyns J, Bureau F, Marichal T. Lung interstitial macrophages: past, present, and future[J]. J Immunol Res, 2018 (2018): 5160794.
|
| 14 |
Gibbings SL, Thomas SM, Atif SM, et al. Three unique interstitial macrophages in the murine lung at steady state[J]. Am J Respir Cell Mol Biol, 2017, 57(1): 66-76.
|
| 15 |
Xing Z, Afkhami S, Bavananthasivam J, et al. Innate immune memory of tissue-resident macrophages and trained innate immunity: re-vamping vaccine concept and strategies[J]. J Leukoc Biol, 2020, 108 (3): 825-834.
|
| 16 |
Watanabe S, Alexander M, Misharin AV, et al. The role of macrophages in the resolution of inflammation[J]. J Clin Invest, 2019, 129 (7): 2619-2628.
|
| 17 |
Orecchioni M, Ghosheh Y, Pramod AB, et al. Macrophage polarization: different gene signatures in M1 (LPS+) vs. classically and M2 (LPS-) vs. alternatively activated macrophages[J]. Front Immunol, 2019 (10): 1084.
|
| 18 |
Bosco MC. Macrophage polarization: reaching across the aisle?[J]. J Allergy Clin Immunol, 2019, 143 (4): 1348-1350.
|
| 19 |
Zhang Y, Li X, Luo Z, et al. ECM1 is an essential factor for the determination of M1 macrophage polarization in IBD in response to LPS stimulation[J]. Proc Natl Acad Sci U S A, 2020, 117 (6): 3083-3092.
|
| 20 |
Zhang L, Wang Y, Wu G, et al. Macrophages: friend or foe in idiopathic pulmonary fibrosis?[J]. Respir Res, 2018, 19 (1): 170.
|
| 21 |
Dong R, Zhang B, Tan B, et al. Long non-coding RNAs as the regulators and targets of macrophage M2 polarization[J]. Life Sci, 2021 (266): 118895.
|
| 22 |
Wang Y, Smith W, Hao D, et al. M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds[J]. Int Immunopharmacol, 2019 (70): 459-466.
|
| 23 |
Wang LX, Zhang SX, Wu HJ, et al. M2b macrophage polarization and its roles in diseases[J]. J Leukoc Biol, 2019, 106 (2): 345-358.
|
| 24 |
赵希伟，周佳伟，刘凯，等.连接蛋白43通过蛋白激酶A介导丝氨酸373调控脓毒症急性肺损伤肺泡Ⅱ型上皮细胞屏障功能的研究[J/CD].中华危重症医学杂志（电子版），2021，14（5）：355-361.
|
| 25 |
Li Y, Huang J, Foley NM, et al. B7H3 ameliorates LPS-induced acute lung injury via attenuation of neutrophil migration and infiltration[J]. Sci Rep, 2016 (6): 31284.
|
| 26 |
Niu X, Zang L, Li W, et al. Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway[J]. Int Immunopharmacol, 2020 (81): 106024.
|
| 27 |
Li X, Huang R, Liu K, et al. Fucoxanthin attenuates LPS-induced acute lung injury via inhibition of the TLR4/MyD88 signaling axis[J]. Aging (Albany NY), 2020, 13 (2): 2655-2667.
|
| 28 |
Wang C, Ma C, Gong L, et al. Macrophage polarization and its role in liver disease[J]. Front Immunol, 2021 (12): 803037.
|
| 29 |
Chen X, Tang J, Shuai W, et al. Macrophage polarization and its role in the pathogenesis of acute lung injury/acute respiratory distress syndrome[J]. Inflamm Res, 2020, 69 (9): 883-895.
|
| 30 |
Bedoui S, Herold MJ, Strasser A. Emerging connectivity of programmed cell death pathways and its physiological implications[J]. Nat Rev Mol Cell Biol, 2020, 21 (11): 678-695.
|
| 31 |
Klionsky DJ, Petroni G, Amaravadi RK, et al. Autophagy in major human diseases[J]. EMBO J, 2021, 40 (19): e108863.
|
| 32 |
Münz C. The macroautophagy machinery in endo- and exocytosis[J]. J Mol Biol, 2017, 429 (4): 473-485.
|
| 33 |
Martin FP, Jacqueline C, Poschmann J, et al. Alveolar macrophages: adaptation to their anatomic niche during and after inflammation[J]. Cells, 2021, 10 (10): 2720.
|
| 34 |
Liu F, Nie C, Zhao N, et al. MiR-155 alleviates septic lung injury by inducing autophagy via inhibition of transforming growth factor-β-activated binding protein 2[J]. Shock, 2017, 48 (1): 61-68.
|
| 35 |
Liu H, Zhou K, Liao L, et al. Lipoxin A4 receptor agonist BML-111 induces autophagy in alveolar macrophages and protects from acute lung injury by activating MAPK signaling[J]. Respir Res, 2018, 19 (1): 243.
|
| 36 |
Qian Q, Cao X, Wang B, et al. Endoplasmic reticulum stress potentiates the autophagy of alveolar macrophage to attenuate acute lung injury and airway inflammation[J]. Cell Cycle, 2020, 19 (5): 567-576.
|
| 37 |
D'Arcy MS. Cell death: a review of the major forms of apoptosis, necrosis and autophagy[J]. Cell Biol Int, 2019, 43 (6): 582-592.
|
| 38 |
Noone PM, Reddy SP. Recent advances in dead cell clearance during acute lung injury and repair[J]. Fac Rev, 2021 (10): 33.
|
| 39 |
Janssen WJ, Barthel L, Muldrow A, et al. Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury[J]. Am J Respir Crit Care Med, 2011, 184 (5): 547-560.
|
| 40 |
Hu R, Chen ZF, Yan J, et al. Complement C5a exacerbates acute lung injury induced through autophagy-mediated alveolar macrophage apoptosis[J]. Cell Death Dis, 2014, 5 (7): e1330.
|
| 41 |
Zhang P, Yu WW, Peng J, et al. LukS-PV induces apoptosis in acute myeloid leukemia cells mediated by C5a receptor[J]. Cancer Med, 2019, 8 (5): 2474-2483.
|
| 42 |
Yang L, Zhang Z, Zhuo Y, et al. Resveratrol alleviates sepsis-induced acute lung injury by suppressing inflammation and apoptosis of alveolar macrophage cells[J]. Am J Transl Res, 2018, 10 (7): 1961-1975.
|
| 43 |
Habashi NM, Camporota L, Gatto LA, et al. Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications[J]. J Appl Physiol (1985), 2021, 130 (3): 877-891.
|
| 44 |
Grant RA, Morales-Nebreda L, Markov NS, et al. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia[J]. Nature, 2021, 590 (7847): 635-641.
|
| 45 |
Fang Y, Tian S, Pan Y, et al. Pyroptosis: a new frontier in cancer[J]. Biomed Pharmacother, 2020 (121): 109595.
|
| 46 |
Frank D, Vince JE. Pyroptosis versus necroptosis: similarities, differences, and crosstalk[J]. Cell Death Differ, 2019, 26 (1): 99-114.
|
| 47 |
Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics[J]. Nat Rev Immunol, 2019, 19 (8): 477-489.
|
| 48 |
Ding H, Yang J, Chen L, et al. Memantine alleviates acute lung injury via inhibiting macrophage pyroptosis[J]. Shock, 2021, 56 (6): 1040-1048.
|
| 49 |
He X, Qian Y, Li Z, et al. TLR4-upregulated IL-1β and IL-1RI promote alveolar macrophage pyroptosis and lung inflammation through an autocrine mechanism[J]. Sci Rep, 2016 (6): 31663.
|
| 50 |
Wu D, Pan P, Su X, et al. Interferon regulatory factor-1 mediates alveolar macrophage pyroptosis during LPS-induced acute lung injury in mice[J]. Shock, 2016, 46 (3): 329-338.
|
| 51 |
Wei LY, Jiang AQ, Jiang R, et al. Protective effects of recombinant 53-kDa protein of Trichinella spiralis on acute lung injury in mice via alleviating lung pyroptosis by promoting M2 macrophage polarization[J]. Innate Immun, 2021, 27 (4): 313-323.
|
| 52 |
Jiao Y, Zhang T, Zhang C, et al. Exosomal miR-30d-5p of neutrophils induces M1 macrophage polarization and primes macrophage pyroptosis in sepsis-related acute lung injury[J]. Crit Care, 2021, 25 (1): 356.
|
| 53 |
Stockwell BR, Jiang X, Gu W. Emerging mechanisms and disease relevance of ferroptosis[J]. Trends Cell Biol, 2020, 30 (6): 478-490.
|
| 54 |
Hirschhorn T, Stockwell BR. The development of the concept of ferroptosis[J]. Free Radic Biol Med, 2019 (133): 130-143.
|
| 55 |
Zhou H, Li F, Niu JY, et al. Ferroptosis was involved in the oleic acid-induced acute lung injury in mice[J]. Sheng Li Xue Bao, 2019, 71 (5): 689-697.
|
| 56 |
Li Y, Cao Y, Xiao J, et al. Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury[J]. Cell Death Differ, 2020, 27 (9): 2635-2650.
|
| 57 |
Liu P, Feng Y, Li H, et al. Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis[J]. Cell Mol Biol Lett, 2020 (25): 10.
|
| 58 |
Xu Y, Li X, Cheng Y, et al. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion[J]. FASEB J, 2020, 34 (12): 16262-16275.
|